Title:
Comparative analysis of cellular immune responses in treated Leishmania patients and hamsters against recombinant Th1 stimulatory proteins of Leishmania donovani

dc.contributor.authorSumit Joshi
dc.contributor.authorNarendra K. Yadav
dc.contributor.authorKeerti Rawat
dc.contributor.authorChandra Dev P. Tripathi
dc.contributor.authorAnil K. Jaiswal
dc.contributor.authorPrashant Khare
dc.contributor.authorRati Tandon
dc.contributor.authorRajendra K. Baharia
dc.contributor.authorSanchita Das
dc.contributor.authorReema Gupta
dc.contributor.authorPramod K. Kushawaha
dc.contributor.authorShyam Sundar
dc.contributor.authorAmogh A. Sahasrabuddhe
dc.contributor.authorAnuradha Dube
dc.date.accessioned2026-02-07T08:17:36Z
dc.date.issued2016
dc.description.abstractOur prior studies demonstrated that cellular response of T helper 1 (Th1) type was generated by a soluble antigenic fraction (ranging from 89.9 to 97.1 kDa) of Leishmania donovani promastigote, in treated Leishmania patients as well as hamsters and showed significant prophylactic potential against experimental visceral leishmaniasis (VL). Eighteen Th1 stimulatory proteins were identified through proteomic analysis of this subfraction, out of which 15 were developed as recombinant proteins. In the present work, we have evaluated these 15 recombinant proteins simultaneously for their comparative cellular responses in treated Leishmania patients and hamsters. Six proteins viz. elongation factor-2, enolase, aldolase, triose phosphate isomerase, protein disulfide isomerase, and p45 emerged as most immunogenic as they produced a significant lymphoproliferative response, nitric oxide generation and Th1 cytokine response in PBMCs and lymphocytes of treated Leishmania patients and hamsters respectively. The results suggested that these proteins may be exploited for developing a successful poly-protein and/or poly-epitope vaccine against VL. © 2016 Joshi, Yadav, Rawat, Tripathi, Jaiswal, Khare, Tandon, Baharia, Das, Gupta, Kushawaha, Sundar, Sahasrabuddhe and Dube.
dc.identifier.doi10.3389/fmicb.2016.00312
dc.identifier.issn1664302X
dc.identifier.urihttps://doi.org/10.3389/fmicb.2016.00312
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/29346
dc.publisherFrontiers Media S.A.
dc.subjectCellular response
dc.subjectImmunogenicity
dc.subjectLeishmania donovani
dc.subjectLymphocytes
dc.subjectPBMCs
dc.subjectRecombinant Th1 stimulatory proteins
dc.subjectTreated Leishmania patients
dc.subjectTreated Leishmania-infected hamster
dc.titleComparative analysis of cellular immune responses in treated Leishmania patients and hamsters against recombinant Th1 stimulatory proteins of Leishmania donovani
dc.typePublication
dspace.entity.typeArticle

Files

Collections